Related references
Note: Only part of the references are listed.The in vitro migration capacity of human bone marrow mesenchymal stem cells:: Comparison of chemokine and growth factor chemotactic activities
Adriana Lopez Ponte et al.
STEM CELLS (2007)
Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells
Lata G. Menon et al.
STEM CELLS (2007)
Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity
J. M. Peron et al.
GUT (2007)
Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes
Manish Aghi et al.
CANCER RESEARCH (2006)
Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC)
Christian Schichor et al.
EXPERIMENTAL NEUROLOGY (2006)
Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo
Wei Zhu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases
Bo-Ra Son et al.
STEM CELLS (2006)
Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors
DG Duda et al.
BLOOD (2006)
Advances toward an understanding of brainstem gliomas
SS Donaldson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Diffuse brainstem glioma in children: critical review of clinical trials
D Hargrove et al.
LANCET ONCOLOGY (2006)
Promoting apoptosis as a strategy for cancer drug discovery
SW Fesik
NATURE REVIEWS CANCER (2005)
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets
V Sordi et al.
BLOOD (2005)
Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas
A Nakamizo et al.
CANCER RESEARCH (2005)
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
BA Peters et al.
NATURE MEDICINE (2005)
Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis (Publication with Expression of Concern. See vol. 295, pg. 8876, 2020) (Withdrawn Publication. See vol. 296, 2021)
T Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model
SA Anderson et al.
BLOOD (2005)
Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution
RF Kelley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4
M Ehtesham et al.
NEOPLASIA (2004)
Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway
J Imitola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
DJ Ceradini et al.
NATURE MEDICINE (2004)
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
K Nakamura et al.
GENE THERAPY (2004)
Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
M Studeny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow
RF Wynn et al.
BLOOD (2004)
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
F Djouad et al.
BLOOD (2003)
Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors
MB Ruzinova et al.
CANCER CELL (2003)
Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens
JA Potian et al.
JOURNAL OF IMMUNOLOGY (2003)
Adult stem cells for tissue repair - A new therapeutic concept?
M Korbling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
S Fulda et al.
NATURE MEDICINE (2002)
Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector
JW Lee et al.
NEOPLASIA (2002)
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
A Ashkenazi
NATURE REVIEWS CANCER (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain -: art. no. RC209
J Dörr et al.
JOURNAL OF NEUROSCIENCE (2002)
Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL
C Voelkel-Johnson et al.
CANCER GENE THERAPY (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro
S Barbero et al.
CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS (2002)
Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells
MJ Knight et al.
ONCOGENE (2001)
Bone marrow stromal stem cells: Nature, biology, and potential applications
P Bianco et al.
STEM CELLS (2001)
Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
KS Aboody et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Gene therapy of experimental brain tumors using neural progenitor cells
S Benedetti et al.
NATURE MEDICINE (2000)
Share Paper
